Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus
Status:
Completed
Trial end date:
2017-06-30
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the pharmacokinetics (PK) of apixaban when co-administered with
cyclosporine and tacrolimus in healthy volunteers. The study participants will receive
apixaban alone, cyclosporine followed by apixaban and tacrolimus followed by apixaban.